3
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Cervical ripening with oral prostaglandin E2 tablets and the effect of the latent period in patients with premature rupture of the membranes at term

, &
Pages 405-408 | Published online: 02 Jul 2009

References

  • Browne M. J., Leon G. D., Dougall A. Oral prostaglandin E2 in the management of patients with spontaneous ruptured membranes and no uterine activity. The Second Upjohn Management of Labour Symposium. Manchester 1989
  • Duff P., Huff R. W., Gibbs R. S. Management of premature rupture of membranes and unfavourable cervix in term pregnancy. Obstetrics and Gynecology 1984; 63: 697–702
  • Ekman‐Ordeberg G., Uldbjerg N., Ulmsten U. Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervixes and premature rupture of the membranes. Obstetrics and Gynecology 1985; 66: 307–310
  • Garite T. J. Premature rupture of the membranes: the enigma of the obstetrician. American Journal of Obstetrics and Gynecology 1985; 151: 1001–1005
  • Gibbs R. S., Blanco J. D. Premature rupture of the membranes. Obstetrics and Gynecology 1982; 60: 671–679
  • Gunn G. C., Mishell D. R., Morton D. G. Premature rupture of the fetal membranes: a review. American Journal of Obstetrics and Gynecology 1970; 106: 469–483
  • Hauth J. C., Cunningham G., Whalley P. J. Early labor initiation with oral PGE2 after premature rupture of the membranes at term. Obstetrics and Gynecology 1977; 49: 523–526
  • Johnson J. W. C., Daikoku N. H., Niebyl J. R., Johnson T. R. B., Khouzami V. A., Witter F. R. Premature rupture of the membranes and prolonged latency. Obstetrics and Gynecology 1981; 57: 547–556
  • Kappy K. A., Cetrulo C. L., Kluppel R. A., Ingardia C. J., Sbarra A. J., Scerbo J. C., Mitchell G. W. Premature rupture of the membranes at term. A comparison of induced and spontaneous labours. Journal of Reproductive Medicine 1982; 27: 29–33
  • Lange A. P., Secher N. J., Nielson F. H., Pederson G. T. Stimulation of labor in cases of premature rupture of the membranes at or near term: a consecutive randomised study of prostaglandin E2 tablets and intravenous Oxytocin. Acta Obstetricia et Gynecolo‐gica Scandinavica 1981; 60: 207–210
  • Naeye R. L., Peters E. C. Causes and consequences of premature rupture of fetal membranes. Lancet 1990; i: 192–195
  • Mahmood T. A., Dick M. J., Smith N. C. Management of spontaneous rupture of the membranes and no uterine activity in healthy primigravi‐dae after weeks gestation. Lancet 1989; i: 34, 721
  • McGregor J. A. Prevention of preterm birth: new initiatives based on microbial‐host interactions. Obstetric and Gynecological Survey 1988; 43: 1–14
  • Schutte M. F., Treffers P. E., Kloosterman G. J., Soepatmi S. Management of premature rupture of membranes. The risk of vaginal examination to the infant. American Journal of Obstetrics and Gynecology 1983; 146: 395–399
  • Shubeck F., Benson R. C., Clark W. W., Berendes H., Weiss W., Deutschberger J. Fetal hazard after rupture of membranes; a report from the collaborative project. Obstetrics and Gynecology 1966; 28: 22–31
  • Wagner M. V., Chin V. P., Peters C. J., Drexler B., Newman L. A. Comparison of early and delayed induction of labour with spontaneous rupture of the membranes at term. Obstetrics and Gynecology 1989; 74: 93–97

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.